Wednesday
SESSION 41: NEW CONCEPTS IN ENDOVASCULAR TREATMENT AND MANAGEMENT OF COMPLICATONS; MORE INFORMATION ABOUT RENAL DENERVATION AND OTHER WAYS TO TREAT RESISTANT HYPERTENSION; AMPUTATIONS
SESSION 41 SCHEDULE
4:50 PM - 4:55 PM We Don’t Need More Endovascular Treatments: Just Better Use Of The Ones We Have
  Presenter(s):Manj S. Gohel, MD, FRCS  
  View Abstract      
4:56 PM - 5:01 PM AAA Wall Microvasculature: How Does It Relate To Thrombus Formation And AAA Growth
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
  View Abstract      
5:02 PM - 5:07 PM Hypercoagulable Testing Is Far Overused In Vascular Patients Whose Revascularizations Fail Repeatedly: What Should We Do To Evaluate Such Patients And When Is Such Testing Helpful
  Presenter(s):Elna M. Masuda, MD  
  View Abstract      
5:08 PM - 5:13 PM A New Simple Technique For Perfusing The Lower Limb To Prevent Ischemia During Prolonged Sheath Obstruction Of The Femoral Arteries During F/B EVAR
  Presenter(s):Johannes Kalder, MD  
  View Abstract      
5:14 PM - 5:19 PM Total Percutaneous Axillary Artery Access In Complex Endovascular Aortic Repair: Technical Tips And Precautions
  Presenter(s):Barend M.E. Mees, MD, PhD  
  View Abstract      
MORE TOPICS ON RESISTANT HYPERTENSION
5:20 PM - 5:25 PM With Respect To Renal Denervation, Where Do The Renal Sympathetic Nerves Lie With Respect To The Renal Artery: Can Radiofrequency (RF) And Ultrasound Inactivate Them And What Effect Do These Modalities Have On The Renal Artery
  Presenter(s):Renu Virmani, MD  
  View Abstract      
5:26 PM - 5:31 PM Is An Arteriovenous Anastomosis The Way To Cure Resistant Hypertension: How Does It Work And Results Of The ROX Arteriovenous Coupler Trial
  Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP  
  View Abstract      
5:32 PM - 5:37 PM Percutaneous Creation Of An A-V Fistula With The ROX Device: Can It Treat Resistant Hypertension And Other Conditions
  Presenter(s):David H. Deaton, MD  
  View Abstract      
5:38 PM - 5:43 PM Is There A Role For Chemoablation For Renal Denervation
  Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA  
  View Abstract      
5:44 PM - 5:49 PM Why The Negative Results Of SIMPLICITY III Are No Surprise: It Does Not Mean The Field Is Dead: Predictions For The Future
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
  View Abstract      
5:50 PM - 6:00 PM Panel Discussion

End of Program E

END OF SESSION 41
previous next